Aesthetic Connect Public Company LimitedSET: TRP🇹🇭 TH

Business Operation · 2024

Corporate Information

Company Name

Aesthetic Connect Public Company Limited

Telephone

092-316-5595

Website

https://teerapornclinic.com

Email

daranee.d@teerapornclinic.com

Dividend Policy

Dividend Policy

Dividend Payment Policy of Aesthetic Connect Public Company Limited


Aesthetic Connect Public Company Limited has a policy to distribute dividends to shareholders at a rate of not less than 50% of the net profit after corporate income tax and legal reserve (if any) for each year. The company will consider dividend payments by taking various factors into account to maximize shareholder benefits. Such dividend payments must not significantly impact the company's normal operations.However, the dividend payment may be subject to change depending on the company’s performance, financial position, liquidity, business expansion plans, necessity, and other relevant factors. The Board of Directors will determine the appropriateness of the dividend payment based on these considerations.

Any resolution of the Board of Directors approving the dividend payment must be proposed for approval at the shareholders' meeting.

However, in the case of interim dividends, the Board of Directors has the authority to approve the payment if it deems that the company has sufficient profits to do so without adversely affecting its operations. The shareholders shall be informed of such payment at the next shareholders' meeting.

Historical Dividend Payments

This YearLast Year2 Years Ago3 Years Ago4 Years AgoMetricDescriptionRemark
0.40.691.040.430.19Net profit per share (Baht : Share)Net profit per share (baht : share)
0.20.41.030.40.18Dividend per share (Baht : Share)Dividend per share (baht : share)
00000Dividend stock ratio (Number of original shares: dividend shares)Ratio of stock dividend payment (existing share : stock dividend)
00000Dividend share value per share (Baht : Share)Value of stock dividend per share (baht : share)
0.20.41.030.40.18Total dividend payment value (Baht : Share)Total dividend payment (baht : share)
50.2372.798.893.3696.91Dividend payout ratio to net profit (%)Dividend payout ratio compared to net profit (%)
- In 2024, the company reported a net profit for the year of 139,367,751.47 THB. Therefore, it is proposed to the meeting for consideration to pay a dividend for the company's performance in 2024. The dividend will be paid in cash at a rate of 0.20 THB per share, amounting to a total value of 70,000,000 THB. All dividends will be subject to withholding tax as prescribed by law. The company will pay the dividend to shareholders according to the list of shareholders as of the Record Date, which is May 8, 2025, and the dividend will be paid on May 26, 2025. - On February 9, 2023, a resolution was passed to change the par value of common shares from 10 baht per share to 0.50 baht per share. Therefore, for the years 2020–2022, the number of shares calculated based on the par value of 0.50 baht per share was used for comparative purposes.

Major Shareholders

Major Shareholders

No.NameShares% Shares
8,280SAN FUN HOLDING CO., LTD.118,800,00033.94
8,281CDR.SUWANNEE JIRAYANGYUEN80,000,00022.86
8,282MR. KRITAPAS JIRAYUNGYURN12,017,9003.43
8,283MR.PAIBOON SEREEWIWATHANA10,232,6002.92
8,284MR. SUPAKORN JIRAYUNGYURN8,015,0002.29
8,285MR. PANIANG PONGSATHA6,604,2001.89
8,286นาย วิทิต พงศ์พิโรดม5,350,0011.53
8,287THAI NDVR CO.,LTD.4,283,5951.22
8,288MISS JUTIMA PATLIDANON3,550,0001.01
8,289MR. MONSON USSAWANOPPAKIAT3,500,0001
8,290MR. KHANTI WIWATWISAWAKORN3,495,9801
8,291MISS SUVIMOL JIRAYUNGYURN3,300,0000.94
8,292น.ส. ศริญญา อุราธรรมกุล3,233,0000.92
8,293น.ส.นวันวัจน์ โตเจริญนิวัติศัย3,083,7000.88
8,294น.ส.ณัฎฐา จิรยั่งยืน3,042,6000.87
8,295นาย สุเมธ จิรยั่งยืน3,020,0000.86
8,296MR. KONGSAK TECHAWIBONPHON3,015,0000.86
8,297MR. PALAPONG CHAYANGSU3,000,0000.86
8,298น.ส. สุวรรณา จิรยั่งยืน3,000,0000.86
8,299MR. CHAIYOT DENARIYAKUL2,659,3000.76
8,300นาย วรดร อธิชลินทร2,370,0000.68

Business Strategies Overview

Chairman's Message

In 2024, Aesthetic Connect Public Company Limited faced challenges from various environmental factors, including the impact of interest rate hikes in developed countries, geopolitical tensions such as the prolonged conflict between Israel and Hamas, which affected the global economy and inflation rates, as well as the slowdown of the Chinese economy and domestic political uncertainties. These factors impacted investor and consumer confidence, potentially leading to a slowdown in investment decisions and household spending. Furthermore, the high level of household debt remains a constraint on spending, which is a key driver of the economy. These factors have affected businesses across almost all industries, preventing them from achieving their growth targets. These challenges are a significant test for the company's business operations, requiring continuous adjustments to our strategies to adapt to these changes promptly. Nevertheless, the company remains committed to continuously developing medical services and technologies to enhance treatment efficacy and elevate medical outcomes, ensuring that we can effectively meet the needs of our clients.

Furthermore, the company has received a five-star rating in the Corporate Governance Report of Thai Listed Companies 2024 (CGR), reflecting the company's excellence in corporate governance. This achievement demonstrates our commitment to all stakeholders while conducting business based on good governance principles to ensure sustainable growth and development, along with our vision to drive social responsibility.

Finally, on behalf of the Board of Directors, we would like to express our sincere gratitude to all medical personnel, executives, employees, shareholders, partners, customers, and stakeholders for your continuous support and trust, as well as your valuable advice to the company throughout the past year. We sincerely hope to receive your continued support. The Board of Directors assures you that we will conduct our business with prudence, transparency, good governance, and business ethics to ensure the company's stable and sustainable growth.



Prof. Dr. Apichati Sivayathorn

Chairman of the Board of Directors

Aesthetic Connect Public Company Limited




Chief Executive Officer


In the past year 2024, Aesthetic Connect Public Company Limited or TRP, a provider of facial plastic surgery services under the name "Teeraporn Clinic," has focused on developing and expanding its services and related businesses to create stronger and more stable growth. Despite facing challenges from the country's economic slowdown and intense competition in the digital market, the company has overcome these obstacles and moved towards sustainable development, thanks to the unwavering trust and confidence from shareholders and clients. The company has been elevated to become the first specialized facial plastic surgery hospital in Thailand, offering a full range of health and beauty services, reflecting its leadership in facial plastic surgery in Thailand. The hospital is scheduled to officially open its doors in the second quarter of 2025.

The company's key operations in 2024 included investing in the construction of a new 5-storey hospital building on Somdet Phrachao Taksin Road. The building boasts a luxurious home-style design, incorporating the unique warmth and friendliness that are synonymous with "Teeraporn," which everyone can experience, with a modern style to accommodate a wide range of services in all dimensions and meet the lifestyles of the hospital's new clients. Another important operation was the opening of TRP Longevity, a center for anti-aging, skincare, beauty, and hair transplantation services, to support the rapid growth of the Skin and Wellness market. This business expansion aims to drive growth and increase revenue. The company has recruited specialized physicians and medical teams with expertise and extensive experience, ready to provide professional services. Additionally, the company has invested in state-of-the-art medical equipment that is popular worldwide to attract new clients seeking facial skincare and post-surgical care, including ULTRA Clear Laser, the world's latest Cold Ablative Fiber Laser innovation, with 4 units available in Thailand. In the field of surgical procedures, the company remains committed to continuously developing its knowledge and service offerings. Recently, the company launched "Facial Contour," a surgical procedure for facial filling and cell-level skin rejuvenation using the patient's own fat tissue containing Stromal Vascular Fraction with Teeraporn's technique. This procedure helps enhance various points on the face, creating dimension and balanced beauty, while rejuvenating the skin to be plump, radiant, and youthful once again. With long-lasting and safe results, this is a business strength of the company that can generate continuous revenue and growth.

In addition, the company has adjusted its strategies, expanded marketing channels, and developed engaging content to reach new customer groups. We have also expanded into international markets, targeting CLM (Cambodia, Myanmar, Laos) and Indonesia. Moreover, we have focused on developing personnel in all departments to support the services provided in the hospital.

On behalf of the management team, we would like to express our sincere gratitude to all shareholders, clients, and agencies for your trust and unwavering support for "Teeraporn." We are committed to developing Thai plastic surgery to international standards while driving the growth and sustainability of our hospital business. We will always uphold our moral principles, medical ethics, and commitment to creating value for society.


Assistant Professor Dr. Choladhis Sinrachatanant

Chief Executive Officer

Aesthetic Connect Public Company Limited

Vision

Vision

An institution that provides surgery, rehabilitation, and total facial care solution for sustainable beauty and global quality.

Mission

Providing care and treatment with professionalism for both Thai and foreigners. Through the development of knowledge in care and treatment to further develop products and academics. Including providing services to society together with developing health products that can be distributed through other channels with international standards in order to be a leader in innovation related to facial beauty.

Values

I. Clients are relatives.

II. Professionalism is key.

III. Innovation.

IV. Staff is family.

Objectives

Provide professional care and treatment for both Thai and foreign customers through the development of care and treatment knowledge to enhance products and academic services. This includes providing services to society in conjunction with developing health products that can be distributed through other channels at international standards to become a leader in facial beauty innovations.

Goals

The company is committed to preparing the organizational structure and expanding its products to support the opening of the hospital in 2025.

Business Strategies

1) Service development with modern medicine and innovations. In operating our business for over 9 years, the company recognizes the importance of customer safety. We focus on providing safe and highly effective services with modern medical technologies and innovations. The company keeps abreast of medical innovations and is always looking for state-of-the-art tools to serve our customers. The company selects service tools that are recognized and inspected by the U.S. Food and Drug Administration (US FDA) and the Food and Drug Administration (FDA) of Thailand, which have been tested and proven safe to ensure that customers receive satisfactory service at all times.

2) Physician team development. As the cosmetic surgery business is highly competitive, the development of surgical techniques is constantly and rapidly changing. Therefore, the company places great importance on the development of its medical team and personnel, starting with the recruitment of physicians and medical personnel with experience, ability, and expertise in both specific and various fields. They are able to learn new medical techniques to develop their potential and support the increasing diversity of customer needs who want beautiful, natural results with less downtime compared to traditional surgery. We support our medical team to conduct research and attend international conferences to build a reputation and confidence that our medical team is a leader in facial surgery in the Asian region.

3) Building brand awareness and recognition. As the beauty and cosmetic surgery business is quite competitive and is gaining popularity, brand awareness and building a brand that impresses consumers is extremely important. The company therefore focuses on creating communications that reach the target group in a variety of attractive ways through both offline and online media, giving doctors a greater role in online media. We also focus on providing a good service experience from consultation to aftercare service.

4) Marketing communications to create brand awareness and recognition for products and services. The company has focused on digital marketing, covering SEO, SEM, Google Ads, as well as communication through social media channels on almost every platform, whether it be YouTube, Facebook, Instagram, Tiktok, Lemon 8, or Line Official Account, with a variety of attractive content. This includes co-developing content with celebrities such as actors, models, celebrities, and beauty bloggers with a large following to create awareness and encourage interest in using the company's services. There is also communication through offline media. The company focuses on measuring and evaluating the effectiveness of each form of communication and each channel systematically in order to develop and maximize the return on investment for the business.

5) Expansion of service scope. The company places importance on the diversity of services to accommodate the different needs of customers. We focus on providing comprehensive beauty services, including cosmetic surgery such as facelifts, double eyelid surgery, rhinoplasty, facial contouring, Botox, Filler, and skincare. Most recently, we opened the "TRP Longevity ", which provides modern holistic anti-aging and wellness services based on medical principles. In addition, the company is committed to continuously researching and developing surgical technologies and innovations in order to meet the needs of customers in the ever-changing era.

6) Price marketing promotion. Due to the highly competitive nature of the beauty and cosmetic surgery business, the company places importance on price marketing promotions to attract customers to use its services. The marketing strategies are as follows: 1) Attracting price-sensitive customers by launching promotions tailored to the target group. Proceeding with case reviews to attract customers to use the service. 2) Converting customers from price-sensitive to non-price sensitive. 3) Increasing billing size by selling more than one surgical procedure at a time or combining both surgical and non-surgical products.

Material Changes & Developments

Material Changes & Developments

YearDescription
2,016

- Aesthetic Connect Company Limited was founded by Cdr.Suwannee Jirayangyuen and family, with a registered capital of 5 million baht. The company operates a medical clinic business under the name "Teeraporn Clinic" to provide facial cosmetic surgery services to the public, such as facelifts (Face-Lock), double eyelid surgery, rhinoplasty, and skincare. The clinic is operated by a team of specialized and experienced doctors with more than 10 years of experience, led by Assistant Professor Dr. Choladhis Sinrachatanant, former president of the Facial Plastic Surgery Society of Thailand, as the Chief Executive Officer.

2,019

- The listed company increased its registered capital from 5 million baht to 100 million baht by issuing and offering 95 million baht worth of newly issued ordinary shares to existing shareholders proportionally (Right Offering). The company will use the proceeds from this capital increase to expand its business.

- The company invested the proceeds from the capital increase to purchase land in the Khlong San district (“Plot 1”), with a size of 0-3-85 rai, to prepare for the expansion of service areas to accommodate the increase in service users, in line with the company's business plan.

- The company has started to increase its marketing through online media in foreign countries such as Cambodia, Laos, and Myanmar.

2,021

- The listed company increased its registered capital from 100 million baht to 130 million baht by issuing and offering 30 million baht worth of newly issued ordinary shares to existing shareholders in proportion to their shareholdings (Right Offering) to support business expansion. The group of shareholders, namely Cdr.Suwannee Jirayangyuen and her family, waived their rights to subscribe for the capital increase in proportion to their entitlement, resulting in other shareholders receiving an increased right to purchase additional shares. This is to boost the morale of those involved or those who are instrumental in creating benefits for the company both directly and indirectly. After the capital increase, the group of shareholders, namely Cdr.Suwannee Jirayangyuen and her family, will have a combined shareholding in the company reduced to 76.92 percent. The offering price is a fair price assessed by an independent financial advisor (IFA) approved by the SEC.

- The company has approved the sale of land plot No. 1 due to a significant increase in the number of facelift patients. As a result, the company has considered selling and purchasing a new land plot with sufficient usable space for future use. Therefore, land plot No. 1 is listed as an investment property in the cash flow statement.

- Certified to ISO: 14064-1 standard.

2,022

- The company invested in land acquisition in the Thonburi area ("Plot 2"), sizing 2-2-83 rai, to prepare for the expansion of service areas to accommodate the increase in service users, in line with the company's business plan.

- The company approved the development of Plot 2 for the construction of a hospital building with a usable area of approximately 9,918 square meters (an increase from the current service area of 1,157 square meters), with completion scheduled for the fourth quarter of 2024.

- Received ISO: 14064-1 certification.

2,023

- The Extraordinary General Meeting of Shareholders No. 1/2023 held on February 9, 2023, resolved as follows:

1) Approval of the transformation from a private limited company to a public limited company.

2) Changed the par value from 10.00 baht per share to 0.50 baht per share.

- The Annual General Meeting of Shareholders for the year 2023 held on March 16, 2023, resolved as follows:

1) Increased registered capital by 45,000,000 baht from 130,000,000 baht to 175,000,000 baht by issuing 90,000,000 ordinary shares with a par value of 0.50 baht per share for the initial public offering (IPO).

- First traded on the Stock Exchange on October 24, 2006 with an IPO price of 14 baht.

- Achieved ISO : 14064-1 certification.

2,024

- The Company signed a business cooperation agreement with Khongkwan Clinic Company Limited (KKC Clinic) on March 12, 2024.

- "Corporate Governance Assessment of Listed Companies for 2024" The company received an "Excellent" (5-Star) rating in the Corporate Governance Report of Thai Listed Companies (CGR) from the Thai Institute of Directors (IOD), reflecting its strong commitment to corporate governance practices.

- Evaluation of the Quality of the 2024 Annual General Meeting of Shareholders" On April 25, 2024, the company received an evaluation score of 92 out of 100 from the Thai Investors Association (TIA). This score reflects the transparency and efficiency of the company in organizing the shareholders' meeting.

- Opened the TRP Longevity , providing holistic health consultations, located on the 3rd floor of Teeraporn Clinic. The center has specialized physicians in anti-aging medicine to provide consultations on common problems associated with aging, such as fatigue, insomnia, hormonal imbalances, and age-related diseases. The physicians will provide personalized consultations and advice tailored to each individual's needs.

- Certified to ISO: 14064-1 standard.

Use of Proceeds from Securities Offerings

Introduction

The company received fundraising proceeds from the stock exchange, with a remaining amount of 1,215.28 million baht after deducting offering expenses. The details of fund utilization as of December 31, 2024, are as follows:

Is There Money Raised from a Securities Offering Still to Report On?

Yes

Offerings

Type of SecuritiesAmount Raised Given AsAmount Raised (Million Baht)Uses of the MoneyUsed as Declared?Progress / Reasons and Measures if Not Used as DeclaredRelated Link
Equity Instruments28731,215.282025-12 · Objective: 1. Investment in hospital construction projects · Period type: 2871 · Start period: 2025-12 · Spent amount type: 2873 · Start spent amount: 285.48 · Expected amount type: 2873 · Start expected amount range: 550.0 · 2025-12 · Objective: 2. Procurement of Medical Equipment and Devices · Period type: 2871 · Start period: 2025-12 · Spent amount type: 2873 · Start spent amount: 10.17 · Expected amount type: 2873 · Start expected amount range: 80.0 · 2023-10 · Objective: 3. Repayment of Loans from Financial Institutions · Period type: 2871 · Start period: 2023-10 · Spent amount type: 2873 · Start spent amount: 95.44 · Expected amount type: 2873 · Start expected amount range: 95.44 · 2025-12 · Objective: 4. To be used as working capital for business operations, other investments, and business expansion (if any) · Period type: 2871 · Start period: 2025-12 · Spent amount type: 2873 · Start spent amount: 0.0 · Expected amount type: 2873 · Start expected amount range: 489.84N

The Board of Directors' Meeting No. 5/2024, held on August 28, 2024, approved an immaterial change in the intended use of funds raised from the Initial Public Offering (IPO). This adjustment involves reallocating 100 million baht from working capital, other investments, and business expansion funds to the hospital construction project. As a result, the working capital, other investments, and business expansion funds decreased from 589.84 million baht to 489.84 million baht, while the hospital construction investment increased from 450 million baht to 550 million baht. Additionally, the timeline for utilizing the funds for the hospital construction project and the procurement of medical equipment has been revised from within 2024 to within 2025 due to delays in project completion beyond the initially planned schedule

https://weblink.set.or.th/dat/news/202501/1836NWS240120251704150401E.pdf?_gl=1*1vugo0h*_gcl_au*NTU2NzgwMjE2LjE3MzQzMzg3ODc.*_ga*OTU0MTY5NTY1LjE3MTg2MDc2Njg.*_ga_ET2H60H2CB*MTc0MTU4NjEwOC4yNTMuMS4xNzQxNTg2OTg0LjI3LjAuMA..

Law Governing the Debt Securities

-The company does not offer debt securities.-

Commitments Made in the Registration Statement

Are There Commitments or Conditions from an Offering or Listing?

No

Group Operating-Structure Policy

Description


None


Shareholders with Potential Conflict of Interest

Has Potential-Conflict Shareholder (Y/N)

No

Relationships Among Major Shareholders

Relationship Exists (Y/N)

No

Shareholders' Agreement

Agreement Exists (Y/N)

No

Shareholding Diagram (Group Structure)

Introduction

The shareholding structure applies only to Aesthetic Connect Public Company Limited, as there are no subsidiaries or associated companies. As of September 26, 2024, the shareholding structure comprises the Jirayangyuen family, which is grouped based on the surname and publicly available information, without considering any relationships or actions that might fall under joint actions with other individuals, in accordance with the Securities and Exchange Commission’s announcement No. T.J. 7/2009. The "group of doctors" refers to physicians working at the clinic, excluding those within the Jirayangyuen family.

Income Structure

Introduction

From 2022 to 2024, the company generated operating revenues of 854.07 million baht, 713.03 million baht, and 554.74 million baht, respectively. The details are as follows:

Product / Service Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenue from operationsTotal revenue from operations554,739.47100713,023.28100854,073.59100
Surgical Services487,209.8487.83657,785.1392.25796,066.3793.21
Intravenous Anesthesia Services23,5254.2430,5304.2836,6154.29
3. Non-Surgical Services22,917.744.1319,5102.7420,957.542.45
OtherOthers21,086.893.85,198.150.73434.680.05

Export Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenueTotal revenue554,739.47100713,023.28100854,073.59100
DomesticDomestic554,739.47100713,023.28100854,073.59100
InternationalInternational000000

Other Income

Operating Other IncomeNon-Operating Other IncomeShare of Profit
1710 · As of year: 21086.88 · Description: Total other income · As of yesteryear: 5198.15 · As of year before yesteryear: 434.69 · 1711 · As of year: 0.0 · Description: Other income from operations · As of yesteryear: 0.0 · As of year before yesteryear: 0.01712 · As of year: 21086.88 · Description: Other income not from operations · As of yesteryear: 5198.15 · As of year before yesteryear: 434.691713 · As of year: 0.0 · Description: Share of profit · As of yesteryear: 0.0 · As of year before yesteryear: 0.0

Product / Service Characteristics

Business Type

3115

Business Groups

Business GroupDescription
1.Surgical procedure services

The company provides surgical procedures that adhere to medical standards, including surgeries requiring intravenous anesthesia under the supervision of expert anesthesiologists. This ensures patient safety and minimizes post-surgical complications. The primary services include:

1.Face-Lock Facelift Surgery

The Face-Lock facelift technique is a surgical innovation developed by Associate Professor Dr. Chonlatit. Sinrattanan and the team of surgeons at Teeraporn Clinic. This technique lifts and tightens all areas of the face, from the forehead to the lower face, reducing sagging and wrinkles while harmonizing facial contours for a youthful appearance. The "Lock System of Teeraporn Clinic" is a groundbreaking facelift technique refined over 20–30 years of research, specifically designed for Asian facial structures. The procedure leaves minimal scars, results in less swelling and bruising, and allows patients to return home immediately without requiring a recovery period.

2.Eye Surgery

2.1 Double Eyelid Surgery (Lucky Eye) with Eye-Lock Technique

The Eye-Lock technique, exclusive to Teeraporn Clinic, was developed by Associate Professor Dr. Chonlatit. Sinrattanan and his medical team. Recognized globally, this technique has been featured in books such as "Less is More My Way" and "Asian Blepharoplasty." It has set the standard for short-incision double eyelid surgery, ensuring aesthetically pleasing results while maintaining strict medical standards. The clinic also offers customized surgical corrections for various eyelid conditions, including upper eyelid muscle adjustments.

2.2 Ptosis Surgery

Ptosis, or drooping eyelids, occurs due to weakened eyelid muscles, leading to visual impairment, eye strain, fatigue, and reduced confidence. Teeraporn Clinic provides medically standardized treatments using a short-incision technique to minimize scarring and accelerate recovery while delivering noticeable results.

2.3 Deep-Set Eye Correction with Fat Augmentation

This procedure addresses deep-set eyes caused by congenital fat deficiency or age-related fat loss. The clinic utilizes fat grafting from the abdomen, to restore volume to the eyelids while complementing double eyelid surgery.

2.4 Additional Eye Surgery Services

These include correction of hidden eyelids, asymmetrical eyelids, multiple eyelid folds, excess eyelid skin removal, under-eye bag surgery, and revision double eyelid surgery from prior unsuccessful procedures at other clinics.


3.Rhinoplasty Surgery

Teeraporn Clinic offers expert consultation and a variety of rhinoplasty techniques tailored to each client's needs. The most common techniques include:

3.1 Silicone and Artificial Tissue Rhinoplasty

This method uses Megaderm (a collagen-based artificial tissue) to reinforce the nasal tip, preventing complications such as thin nasal skin or implant extrusion. This technique is ideal for individuals with thin nasal skin who want a more projected nose tip without harvesting ear cartilage.


3.2 Autologous Fat Grafting Rhinoplasty

Developed by Associate Professor Dr. Choladhis. Sinrachatanant 1993, this technique uses fat extracted from the thighs or lower abdomen to enhance the nose naturally. It was created as an alternative to liquid silicone injections, which often led to deformities. This method improves nasal shape while avoiding foreign materials, making it ideal for patients with silicone allergies or previous nasal implant complications. Associate Professor Dr. Choladhis and his team have compiled their expertise in "Masterclass Rhinoplasty," a resource for advancing surgical education in rhinoplasty.


3.3 Nose Surgery with Structural Modification Technique (Open Nose Reconstruction) Nose surgery with the structural modification technique focuses on correcting and adjusting the structure of the nose to be balanced and proportionate to the individual's physique. The procedure uses the Open Rhinoplasty technique, which involves making an incision at the base of the nose, allowing the surgeon to clearly view the internal structure of the nose. This enables the surgeon to resize the nasal base, adjust the shape of the nose to appropriate proportions, and refine the nasal tip for a slimmer appearance. This type of surgery is suitable for individuals who need to alter their nasal structure in a way that cannot be corrected using the closed rhinoplasty technique, which only involves the use of silicone or synthetic medical materials. A key feature of nose surgery with the structural modification technique is the ability to use various materials, not just synthetic materials. The surgeon can also use materials taken from the patient’s own body, which are safer and reduce the risk of adverse reactions from the body. The materials that can be used to modify and reconstruct the nose include:

• Septal Cartilage – This is a flat, straight, smooth, and strong cartilage found in the middle septum of the nose. It is the only area in the body suitable for augmenting the nasal tip.

• Ear Cartilage – This is used when the septal cartilage is too small and insufficient for nasal tip enhancement.

• Rib Cartilage – This is used when the septal cartilage is too small, and stronger cartilage is required for structural enhancement, especially at the nasal tip.


4. Additional Cosmetic Surgeries

Apart from the above services, the company also offers other surgical procedures, including:

-Brow Lift (Brow Lock)

-Sub-Brow Lift (Sub Brow Lock)

-Neck Lift (Neck Lock)

-Chin Augmentation

-Forehead Lift (Forehead Lock)

-Hair Transplant Surgery

Investors and interested individuals can find more details on the company’s website.

2.Intravenous anesthesia services

Intravenous Anesthesia Services at Teeraporn Clinic

Since all surgical procedures performed at Teeraporn Clinic are minor surgeries, intravenous anesthesia is administered in appropriate amounts before surgery to ensure patient comfort. This method allows patients to reach a state of light sleep while maintaining their ability to breathe independently, making it a safer alternative to general anesthesia due to its lower risk of side effects.

Intravenous anesthesia is provided based on the type of surgical procedure or upon the patient’s request. During surgery, an anesthesiologist oversees patient safety by monitoring vital signs and administering additional medication as needed to ensure a smooth and safe procedure.

3.Non-surgical services

Non-Surgical Services In addition to the aforementioned surgical services, the company offers a range of non-surgical skin and aesthetic treatments, including:

3.1 Botox Injections for Wrinkle Reduction and Facial Contouring Botox (Botulinum toxin type A) is derived from the Clostridium botulinum bacterium. When injected, it acts as a neurotoxin, temporarily reducing muscle activity. This helps smooth wrinkles and fine lines, particularly on the forehead, between the eyebrows, and around the eyes. It is also used for facial contouring by reducing the size of the jaw muscles and tightening the facial structure. Results typically appear within 3 to 14 days after injection.

3.2 Filler Injections for Wrinkle Reduction and Facial Contouring Filler injections use Hyaluronic Acid (HA), a naturally occurring substance in the body. This treatment is effective for filling deep lines, restoring lost volume, and improving skin smoothness. Fillers are safe, naturally dissolvable, and help retain moisture for hydrated, youthful skin. The effects typically last around one year.

3.3 High-Intensity Focused Ultrasound (HIFU) for Skin Tightening HIFU technology stimulates collagen production across different layers of the skin, encouraging new, firmer tissue formation. It improves skin elasticity, minimizes pores, softens the skin, and reduces neck wrinkles. Visible results can be seen after the first session, with long-term benefits in preventing skin sagging.

3.4 Ultherapy for Lifting and Firming Ultherapy is a non-surgical facelift technique that stimulates collagen production deep within the SMAS layer of the skin—the same layer targeted in surgical facelifts. This process tightens loose skin and restores firmness without the need for surgery.

3.5 Vitamin Injections for Skin Brightening Vitamin infusions, including Vitamin C, B1, B6, B12, and essential amino acids, help repair and rejuvenate weakened skin cells. These concentrated natural extracts also inhibit melanin oxidation, reducing redness and skin discoloration within three days. Suitable for all skin types, including oily, dry, and combination skin.

3.6 Other Skincare Treatments Additional skincare services include LED light therapy, collagen injections, and full-face skin rejuvenation treatments.

3.7 Anti-Aging and Wellness Services This department focuses on health restoration and rejuvenation through treatments such as immune system assessments, vitamin therapies (both oral and injectable), and other regenerative health solutions.

Research & Development

Has R&D Policy (Y/N)

Yes

Introduction

The company places great importance on and actively promotes research and development of new products to enhance its capability in delivering innovations and new offerings that meet the needs of customers both now and in the future. This initiative strengthens the company’s image as an industry leader while also improving internal processes to ensure operational efficiency and agility. These details are disclosed in the sustainability management report under the social dimension.

R&D Cost — Description

The company focuses on excellence in facial beauty care by a team of medical specialists with an average of more than 17 years of experience and continues to strive to develop surgical techniques. Both facelifts Eyes and nose to build a reputation and build confidence that the company's medical team is a leader in facial surgery in Asia. In addition, the medical team is also medical professors within the organization. By giving advice to specialist doctors to the next generation of medical teams to become experts and be able to create results at an excellent level. The main medical specialist groups are defined as Facelift specialist (Face Lock), eye surgery specialist and nose specialist. There is a clear teaching plan and select doctors to join the team from specialized doctors. In order to have a medical team that has potential and is sufficient to grow the business according to the goals set each year.

In addition to facelift surgery nose and eyes using currently available techniques. The medical team is also committed to developing new techniques and to meet the needs of the changing characteristics of service recipient groups that is the Silver age group, which is the age group of 55 years who are interested in taking care of their health and has high paying power In this group, there are also surgeries that match this group, such as surgery for bags under the lower eyes. Eye muscle weakness surgery It is more common in people who are getting older, but it is not known whether this disorder can be treated. or nose surgery with fat and artificial tissue This is a new technique that will answer the needs of people who have had nose surgery with silicone and have had complications and do not want to use silicone again. With services that meet the needs of this silver age group, the medical team together with the marketing team will develop public relations media to educate the public and show true leadership in facial cosmetic surgery. in all channels, both online and offline. Moreover, in medical development, the company also focuses on developing people in other areas, such as service. The company organizes both internal and external training to develop the service capabilities of its personnel to meet service standards in order to create the highest satisfaction and create a good experience for customers who use the service. In terms of sales, the company has employees answer questions and salespeople participate in various development training to increase their sales potential.

And in addition to providing services to Thai people in the country and Thai people abroad. In the past, the company also plans to concretely expand its services to neighboring countries such as Cambodia, Myanmar and China, which are large markets and have paying power by modifying online media and websites to be available in multiple languages. This new market can be reached through agent channels. There will be training for representatives in each country to understand products and services. Comprehensive care Both accommodation and travel so that foreign service recipients will have an impressive experience because the company treats customers like family. and create word of mouth to other customers further because the company believes that Word of Mouth is the strongest and most sustainable marketing strategy.

Finally, in terms of expanding the scope of services, the company emphasizes the variety of services in order to be able to respond to the diverse needs of customers. In addition to the company's current services, the company is also studying the possibility of expanding its services to include surgeries in other parts of the body, as well as providing maintenance and anti-aging medicine services, so that the company has comprehensive services and can always respond to the diverse needs of customers.

R&D Cost — Label

Research and development (R&D) expenses over the past 3 years (Million Baht)

R&D Cost — This Year

0.0

R&D Cost — Last Year

0.0

R&D Cost — 2 Years Ago

0.0

Assets Used in the Business

Permanent Assets — Description

The Company’s Key Fixed Assets ,The company’s key fixed assets used in business operations as of December 31, 2024, are detailed in the financial statements attached as Appendix 4, as follows:

1) Land, Buildings, and Equipment

Land 1 – Ownership: Company, Net Book Value: THB 306.26 million

Leasehold Improvements – Ownership: Company, Net Book Value: THB 0.59 million

Medical Equipment and Instruments – Ownership: Company, Net Book Value: THB 5.19 million

Office Equipment and Supplies – Ownership: Company, Net Book Value: THB 3.97 million

Vehicles – Ownership: Company, Net Book Value: THB 1.85 million

Assets Under Installation and Construction in Progress – Ownership: Company, Net Book Value: THB 412.50 million

Total Net Book Value of Land, Buildings, and Equipment: THB 730.36 million

Note: Land 1 As of December 31, 2024, the company owns a plot of land with title deed number 13449, covering an area of 2 rai, 2 ngan, and 83 square wah, located in Bukkhalo Subdistrict (Bang Sai Kai), Thon Buri District (Bangkok Yai), Bangkok. The land is currently being used for the construction of a hospital building.


2) Land

AESTHETIC CONNECT PUBLIC COMPANY LTD.

Location : Bang Sai Kai Subdistrict, Fang Nuea, Khlong San District (Bang Lamphu) Bangkok 10600

Land : 385 square wah,

Title Deed No. 1917

Owner

Total Net Book Value: THB 89.14 million


3) Right-of-Use Assets (As of December 31, 2024)

Office Building – Net Book Value: THB 2.27 million

Vehicles – Net Book Value: THB 1.15 million

Office Equipment – Net Book Value: THB 0.21 million

Total Net Book Value of Right-of-Use Assets: THB 3.63 million


4) Software Usage Rights (As of December 31, 2024)

Computer Software

Total Net Book Value: THB 0.18 million

Permanent Assets — Appraisal

AssetOwnershipObligationAppraisal Value
LandOwnernone89.14

Intangible Assets — Description

As of December 31, 2024, the details and net book value of the company’s intangible assets, as reflected in the company’s financial statements, are as follows:

Computer software license Cost: 3.69 million baht.

Less: Accumulated amortization (1.15) million baht.

Net book value: 2.54 million baht.

Has Subsidiaries Investment Policy (Y/N)

Yes

Subsidiaries Investment Policy — Description

Aesthetic Connect Co., Ltd. (Public) ("the Company") has an investment policy, which includes the governance of its subsidiaries and associates. The Company will invest in businesses that are related, complementary, or provide benefits and support to the Company's operations, while considering the returns for all stakeholders. This is aimed at strengthening the stability and performance of the Company. Furthermore, in governing the operations of its subsidiaries and associates, the Company's Board of Directors will consider appointing qualified representatives with appropriate experience in the related business of the invested company as directors of the subsidiaries and associates. This is to ensure that the Company can govern the operations of its subsidiaries and associates as if they were part of the Company. The Company places great importance on having a good management system that is transparent and auditable, as it helps protect the interests of the Company's investments. The Company, therefore, requires its representatives to manage the subsidiaries and associates in the best interests of the Company, while ensuring compliance with the relevant laws governing the operations of the subsidiaries and associates. Additionally, the appointment of representatives as directors in the subsidiaries and associates will be in proportion to the Company’s shareholding in these entities. The Company ensures that its subsidiaries have an appropriate and sufficient internal control system to prevent potential fraud, as well as a clear operational system to ensure that there are adequate and reliable systems for disclosing significant transactions according to established criteria on a continuous basis. The Company also establishes mechanisms for auditing these systems within the subsidiaries, allowing the internal audit team and independent directors to have direct access to the information. The results of the audits will be reported to the executive committee or the Board of Directors to ensure that the subsidiaries consistently adhere to the established operational systems. The Company will closely monitor the performance and operations of its subsidiaries and associates, including overseeing the disclosure of related transactions and ensuring the proper collection and recording of data and accounts for audit by the Company. Regular reports will be made to the executive committee or the Board of Directors for continuous planning and setting goals for future operations.

Marketing Policy & Competition

Reporting Mode

3117

Marketing Policy (Overall)

1.Enhancing Marketing Quality Both Offline and Online

The company aims to strengthen both offline and online marketing by implementing activities that can reach all customer segments. This includes offline events such as product launch events and seminars providing consultations on cosmetic surgery, beauty, and healthcare. Additionally, the company will leverage various online platforms such as social media (Facebook, Instagram, TikTok, YouTube) and its website to engage both new and existing customers through compelling and relevant content.

2.Utilizing Presenter-Based Marketing The company will adopt presenter-based marketing by collaborating with well-known figures who have influence in the beauty and healthcare industries, such as celebrities and influencers. These presenters will help enhance the brand’s appeal and credibility, making it easier for customers to trust the company’s services. They will play a key role in effectively communicating the value of the company’s products and services, ensuring better customer engagement.

3.Focusing on the Southeast Asian (SEA) Market The company will expand its marketing strategies to target the Southeast Asian (SEA) market, which is experiencing rapid growth in the beauty and wellness industries. This will involve tailoring communication approaches to align with the cultural preferences and trends of each country. The company will also launch country-specific campaigns to attract new customers and strengthen its customer base within the SEA region.


Service Capacity

As of December 31, 2024, Teeraporn Clinic has six surgical operating rooms, with a maximum combined service capacity of 21,900 hours per year.


Target Customer Characteristics

The company's service recipients are aged 20 and above, with middle to high income levels. They can be categorized into three groups based on their cosmetic surgery needs:

Customers aged 20-30 years – This group primarily seeks double eyelid surgery and rhinoplasty.

Customers aged 30-45 years – These customers have strong purchasing power and diverse cosmetic surgery needs. The most common procedures include double eyelid surgery, rhinoplasty, brow lift, canthoplasty (outer eye corner lift), and in some cases, facelift surgery to address concerns about facial wrinkles.

Customers aged 45 and above – This group has high purchasing power and often experiences issues such as wrinkles, drooping eyelids, sagging brows, or hair loss. They typically seek procedures such as facelift surgery, forehead lift, and fat grafting to restore facial volume and reduce sagging due to aging.


Distribution Channels

Currently, the company operates a single establishment, Teeraporn Clinic, located at No. 2 Charoen Nakhon Road, Khlong San Subdistrict, Khlong San District, Bangkok, with a usable area of approximately 1,157 square meters. In addition, the company distributes its services through authorized agencies/partners, which can be individuals or legal entities with an interest in cosmetic surgery and a network of potential clients interested in undergoing procedures at Teeraporn Clinic. The company has established clear qualifications and compensation structures for its authorized agencies. However, the company maintains a policy that prohibits directors, executives, related persons, or stakeholders of the company from acting as authorized agents.

Communication Channels The company utilizes both offline and online communication channels to engage with customers and potential clients. Offline Communication Customers or interested individuals can inquire about services in person at Teeraporn Clinic or contact the central phone number for initial consultations and to schedule an appointment with a doctor. Online Communication The company has significantly expanded its online communication channels to enhance accessibility and provide educational content on facial cosmetic surgery. Most customers prefer to inquire through the company’s online platforms, such as the official website and social media platforms, including Facebook, Instagram, and Line Official, due to their convenience and speed. As part of their decision-making process, customers tend to research aesthetic procedures beforehand, often by: Reviewing shared cosmetic surgery information on social media Reading reviews of renowned surgeons Comparing the advantages and disadvantages of different hospitals and clinics Assessing preliminary costs of their desired procedures By actively maintaining communication channels on social media, Teeraporn Clinic fosters customer engagement while leveraging these platforms as effective marketing tools. They enable the company to reach target audiences efficiently through both mass advertising and targeted advertising campaigns. As of December 31, 2024, the company’s online communication channels had the following number of followers:

Facebook: 520,000 followers

YouTube: 163,000 followers

Line Official: 84,000 followers

TikTok: 69,100 followers

Instagram: 18,500 followers

All media and advertisements published through Teeraporn Clinic’s various channels are regulated by the Department of Health Service Support. The company holds official approvals for advertising related to medical facilities on websites, YouTube, TikTok, Instagram, Line, Facebook, and Google My Business. Before any advertisement is published, the company ensures that it complies with the 2019 Announcement of the Department of Health Service Support on Advertising Guidelines, Methods, Conditions, and Fees for Medical Facilities, specifically Section 2, Clause 8, to ensure legal and ethical compliance.


Industry & Competition (Overall)

Overview of the Aesthetic Surgery Market in Thailand The aesthetic surgery market in Thailand has been experiencing continuous growth due to various factors such as:


1.Attraction of International Clients: Thailand’s medical industry has gained global recognition for its image and the high quality of services provided by medical staff and doctors. This has significantly increased the demand from international clients. Additionally, Thailand’s renowned tourist destinations have attracted health tourists (Medical Tourism), further boosted by government economic stimulation programs, including offering free visas for many countries.

2.Popularity of Korean Beauty Industry: The global popularity of Korean Soft Power, including K-pop music, K-series dramas, K-movies, influencers, and the emphasis on physical appearance in Korea—believed to impact career opportunities—has had a strong influence not only in South Korea but also in Thailand, contributing to the rise of beauty and cosmetic surgery trends.

3.Openness and Social Acceptance: Social changes and shifts in attitudes, such as influencers openly discussing their cosmetic surgery experiences, acceptance of diverse body shapes, and support for individuality, have all contributed to increased confidence in undergoing surgery. The easy access to information and reviews detailing the surgical process and expected outcomes has further boosted public trust in cosmetic surgery.

4.Medical Innovations: Medical advancements, such as the unique surgical techniques developed by Teeraporn Clinic, which minimize scars, reduce swelling, and allow patients to return home immediately without overnight stays, have addressed many concerns regarding post-surgery recovery. These innovations have helped change the public perception of cosmetic surgery, making it less intimidating than in the past.

From a business competition perspective, the beauty industry is highly competitive, with intense rivalry in terms of pricing and market demand. This is driven by the opening of numerous new hospitals and the expansion of branches by private clinics offering beauty services. In response, the company has positioned itself in the market by focusing on providing high-standard surgical services, featuring modern operating room systems, as well as a team of highly skilled and experienced medical professionals.

Procurement of Products & Services

Reporting Mode

3117

Procurement (Overall)

Recruitment of Doctors and Medical Personnel

Doctors and medical personnel are the core of the facial cosmetic surgery business, as they are essential for every procedure. The company has established multiple recruitment channels, including its website, job search platforms, and referrals within the medical community. As of December 31, 2024, the company employs the following medical personnel:

Doctors: 25

Nurses and Assistant Nurses: 15

The company follows a strict selection and hiring process to ensure that all recruited medical personnel possess the necessary qualifications and valid professional licenses certified by relevant authorities. Background checks and document verification are conducted, including: Medical degree certificates Professional practice licenses Specialist diplomas Subspecialty or facial plastic surgery certificates Registration certificates Training certifications Experience verification documents

These measures are in place to prevent unauthorized individuals from falsely presenting documents to practice medicine unlawfully. The hiring process also considers workforce requirements. Additionally, all doctors working with the company, regardless of prior surgical experience from other medical institutions, must undergo specialized training provided by senior company doctors. This ensures that all procedures follow the company’s proprietary techniques (such as those developed by Teeraporn Clinic), maintaining consistent quality and service standards for clients.


Procurement of Medicines, Medical Supplies, and Equipment

The company sources products from domestic suppliers or official distributors in Thailand, certified by the Thai Food and Drug Administration (FDA) or the U.S. Food and Drug Administration (US FDA). These organizations are recognized both nationally and internationally. Key products include various medications, surgical sutures, artificial tissues, nasal implants, Botox, and fillers. The company adheres to standardized storage practices for medicines and medical supplies, conducting regular quality and expiration date checks to ensure that only high-quality products are used for client treatments.

Additionally, the company evaluates and reviews its list of medicine, medical supply, and equipment suppliers based on product and service quality, delivery performance, and other criteria using a supplier performance assessment form. Each delivery undergoes evaluation, and an annual summary is conducted to assess supplier performance. Suppliers failing to meet the required standards may be removed from the approved vendor list upon management approval. The company procures medicines, medical supplies, and equipment from multiple suppliers and does not have exclusive purchasing agreements with any specific supplier.

In 2024, the company made purchases from one supplier accounting for more than 10% of the total purchases as per the consolidated financial statements. These include: DKSH (Thailand) Co., Ltd., a world-leading company with expertise and quality in the distribution of pharmaceuticals, medical supplies, and medical devices. Cilic Pharma Co., Ltd., a major distributor of pharmaceuticals, medical supplies, and medical devices in the country, offering a wide range of products. The aforementioned business partners have consistently demonstrated strong operational capabilities, being able to respond to the company's needs quickly and efficiently.

Nature of Business — Overview

Introduction

The company operates in the field of facial cosmetic surgery and modern, holistic healthcare based on medical principles. It focuses on service quality through a team of specialized doctors, including experts in various fields, and utilizes medical equipment and tools that meet high standards with a strong emphasis on the safety of the customers. The company's commitment to quality service has resulted in increased trust in the brand, leading to customer satisfaction and continuous growth.

Projects Under Construction

Has Projects Under Construction (Y/N)

No

Debentures & Bills of Exchange

Has Debentures (Y/N)

No

Convertible Securities

Has Convertible Securities (Y/N)

No

Contents